In this review:
Cancer prevention with aspirin in hereditary CRC
Long-term CRC incidence/mortality following negative screening colonoscopy
Prognostic/predictive value of Immunoscore in stage III colon cancer
BRAF-mutant subtypes and treatment outcome in CRC
Panitumumab + irinotecan vs cetuximab + irinotecan for KRAS wt mCRC
Prognostic impact of immunemicroenvironment in colorectal liver metastases
Combined immune checkpoint inhibition in advanced CRC
Preoperative irinotecan completion in locally advanced rectal cancer
Treatment options in RAS mutant metastatic CRC
Short-course radiotherapy/preoperative chemotherapy for high-risk rectal cancer
Please login below to download this issue (PDF)